Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in TaxesChange in TaxesDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares OutstandingShares OutstandingShares Repurchased
Ratios

Alcon (ALC) Shares Repurchased (2009 - 2026)

Alcon's quarterly Shares Repurchased came in at -$75.0 million in Q1 2026, up 75.57% quarter-over-quarter from -$307.0 million in Q4 2025.

Alcon has reported Shares Repurchased for 4 years, with the latest figure at -$75.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Shares Repurchased changed N/A year-over-year to -$75.0 million; the trailing twelve-month figure through Mar 2026 stood at -$573.0 million (changed N/A YoY), and the FY2025 full-year result was -$676.0 million, changed N/A from the prior year.
  • Shares Repurchased for Q1 2026 stood at -$75.0 million, up from -$307.0 million in the prior quarter.
  • The five-year high for Shares Repurchased was -$75.0 million in Q1 2026, with the low at -$307.0 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Repurchased (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 1.12 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 2.00 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 175.01 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 297.60 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 67.00 Mn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 92.50 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 31.20 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn -
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 99.97 Mn
10 Alcon 26,430.30 -1.58 Bn 1.53 Bn -75.00 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -75.00 Mn
Mar 31, 2026 -75.00 Mn
Dec 31, 2025 -307.00 Mn
Dec 31, 2025 -307.00 Mn
Sep 30, 2025 -253.00 Mn
Sep 30, 2025 -253.00 Mn
Dec 31, 2010 62.00 Mn
Dec 31, 2010 62.00 Mn
Sep 30, 2010 -17.00 Mn
Sep 30, 2010 -17.00 Mn
Jun 30, 2010 -3.00 Mn
Jun 30, 2010 -3.00 Mn
Mar 31, 2010 -9.00 Mn
Mar 31, 2010 -9.00 Mn
Dec 31, 2009 12.00 Mn
Dec 31, 2009 12.00 Mn
Jun 30, 2009 -9.00 Mn
Jun 30, 2009 -9.00 Mn
Mar 31, 2009 4.00 Mn
Mar 31, 2009 4.00 Mn